Less Ads, More Data, More Tools Register for FREE

Pin to quick picksACRL.L Regulatory News (ACRL)

  • There is currently no data for ACRL

Senior Management Change

10 Apr 2019 07:00

RNS Number : 6771V
Accrol Group Holdings PLC
10 April 2019
 

 

10 April 2019

 

Accrol Group Holdings plc

("Accrol" or the "Group")

 

Senior Management Change: Appointment of Group Finance Director

 

Accrol, the UK's leading independent tissue converter, is pleased to announce that John Pilkington has accepted the permanent role of Group Finance Director with immediate effect.

 

John joined the senior management team of Accrol in September 2018, as Group Financial Controller. Since then, he has gained a strong understanding of the business and its financials and has been closely involved in the latter stages of the turnaround process.

 

John qualified as a Chartered Accountant with KPMG and has nearly 20 years' experience as a senior finance executive, including over 10 years with Promethean World Limited (formerly Promethean World Plc), latterly as Group Financial Controller.

 

Hannah Argo, who was appointed Interim Chief Financial Officer whilst a search for a permanent replacement was undertaken, has completed her contract and leaves the Company today.

 

Dan Wright, Executive Chairman of Accrol, said: "We are delighted that John has accepted the role of permanent Group Finance Director. His knowledge and understanding of the Group, gained during an intense and difficult period for the Group, will allow him to hit the ground running. The Board has been thoroughly impressed with his contribution and commitment to the business over the last seven months and we look forward to working with him even more closely."

 

"On behalf of all the directors, I thank Hannah for stepping into the role of Interim CFO and for her work during this time."

The Board remains unchanged, comprising Dan Wright (Executive Chairman), Gareth Jenkins (Chief Executive Officer), Euan Hamilton (Non-Executive) and Simon Allport (Non-Executive).

 

For further information, please contact:

 

 

 

Accrol Group Holdings plc

 

Dan Wright, Executive Chairman

Tel: +44 (0) 1254 278 844

Gareth Jenkins, Chief Executive Officer

 

 

 

Zeus Capital Limited (Nominated Adviser & Broker) 

 

Dan Bate / Andrew Jones

Tel: +44 (0) 161 831 1512

Dominic King / John Goold

Tel: +44 (0) 203 829 5000

 

 

Belvedere Communications Limited

 

Cat Valentine (cvalentine@belvederepr.com)

Tel: +44 (0) 7715 769 078

Keeley Clarke (kclarke@belvederepr.com)

Tel: +44 (0) 7967 816 525

Llew Angus (langus@belvederpr.com)

Tel: +44 (0)7407 023 147

 

Notes to Editors

 

Accrol Group Holdings plc, based in Lancashire, is a leading tissue converter and supplier of toilet rolls, kitchen rolls and facial tissues, as well as other tissue products, to major discounters and grocery retailers throughout the UK. Accrol operates from three sites:

 

·

A manufacturing, storage and distribution facility in Blackburn;

·

A facial tissue plant, also in Blackburn; and

·

A manufacturing, storage and distribution facility in Leyland.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BOALLFIRSDIAIIA
Date   Source Headline
22nd May 20186:25 pmRNSPosting of Cricular
22nd May 20187:00 amRNSOpen Offer
22nd May 20187:00 amRNSTR1
15th May 20185:16 pmRNSPosting of Circular
15th May 20183:08 pmRNSProposed Placing to raise £8 million
3rd May 20187:00 amRNSHolding(s) in Company
1st May 20182:06 pmRNSSecond Price Monitoring Extn
1st May 20182:00 pmRNSPrice Monitoring Extension
1st May 20187:00 amRNSRevised Banking Arrangements & Operational Update
4th Apr 20185:06 pmRNSDirector Shareholding
29th Mar 20183:26 pmRNSTR1: Standard form
29th Mar 20187:00 amRNSTR-1: Standard form
27th Mar 20183:43 pmRNSStatement re Share Price Movement
26th Mar 20184:41 pmRNSSecond Price Monitoring Extn
26th Mar 20184:35 pmRNSPrice Monitoring Extension
21st Mar 201812:32 pmRNSHolding(s) in Company
19th Mar 20187:00 amRNSTrading Update
15th Feb 20185:55 pmRNSDirector/PDMR Shareholding
13th Feb 20187:00 amRNSDirector/PDMR Shareholding
8th Feb 20184:31 pmRNSDirector/PDMR Shareholding
5th Feb 20187:00 amRNSBoard Changes
23rd Jan 20181:16 pmRNSPDMR Dealings
22nd Jan 20187:01 amRNSInterim Results for six months ended 31 Oct 2017
22nd Jan 20187:00 amRNSBoard Change
17th Jan 20183:25 pmRNSUpdate on Health and Safety Incident
4th Jan 20187:00 amRNSTR-1: Standard form
3rd Jan 20187:00 amRNSNotice of Half Year Results
13th Dec 201710:57 amRNSHolding(s) in Company
12th Dec 20177:00 amRNSHolding(s) in Company
11th Dec 20178:02 amRNSDirectors' Dealings
11th Dec 20178:01 amRNSPlacing Shares Admitted
8th Dec 201711:09 amRNSResult of General Meeting
30th Nov 20177:00 amRNSReplacement - TR-1
29th Nov 20172:05 pmRNSTR-1: Standard form
21st Nov 20174:40 pmRNSSecond Price Monitoring Extn
21st Nov 20174:35 pmRNSPrice Monitoring Extension
21st Nov 20177:00 amRNSPosting of Circular
20th Nov 20177:30 amRNSRestoration - Accrol Group Holdings Plc
20th Nov 20177:00 amRNSProposed Placing of £18m and Lifting of Suspension
12th Oct 20174:05 pmRNSUpdate on Health and Safety incident
9th Oct 20177:00 amRNSUpdate on Suspension of Trading on AIM
5th Oct 20177:30 amRNSSuspension - Accrol Group Holdings Plc
5th Oct 20177:00 amRNSTrading Update and Temporary Suspension of Trading
22nd Sep 20172:47 pmRNSResult of AGM
19th Sep 20173:16 pmRNSHolding(s) in Company
7th Sep 20177:00 amRNSAppointment of Chief Executive and Trading Update
10th Aug 20177:00 amRNSPosting of Accounts & Notice of AGM (Replacement)
9th Aug 20177:00 amRNSPosting of Accounts & Notice of AGM - Date change
10th Jul 20177:01 amRNSAppointment of Joint Corporate Broker
10th Jul 20177:00 amRNSPreliminary results for year ended 30 April 2017

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.